Is the prognostic significance of O6-methylguanine- DNA methyltransferase promoter methylation equally important in glioblastomas of patients from different continents? A systematic review with meta-analysis

Abstract

BACKGROUND O6-methylguanine-DNA methyltransferase (MGMT) is an independent predictor of therapeutic response and potential prognosis in patients with glioblastoma multiforme (GBM). However, its significance of clinical prognosis in different continents still needs to be explored. PATIENTS AND METHODS To explore the effects of MGMT promoter methylation on… (More)
DOI: 10.2147/CMAR.S140447

Topics

8 Figures and Tables

Cite this paper

@inproceedings{Meng2017IsTP, title={Is the prognostic significance of O6-methylguanine- DNA methyltransferase promoter methylation equally important in glioblastomas of patients from different continents? A systematic review with meta-analysis}, author={Wei Meng and Yangyang Jiang and Jie Ma}, booktitle={Cancer management and research}, year={2017} }